Not provided
Not provided
Not provided
Not provided
Not provided
Corrupted data
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this interventional study is to evaluate the DNN Noise reduction feature of Phonak hearing aids in adults with moderate to moderate severe hearing loss. The main questions it aims to answer are:
Do participants correctly identify significantly more words on the AZBio Sentence Test when using Phonak's DNN NR feature than when using Competitor device A in a lab setting? Do participants subjectively rate the speech clarity, ease of listening, and listening confidence higher when using Phonak's DNN feature than when using Competitor device A in both a lab setting and a real-world cafe setting? Do participants have an overall preference for the Phonak device over the Competitor device A in a real-world cafe setting?
Participants will be fit with both the Phonak device and a Competitor device A in the lab. They will be given the AZBio Sentence test and repeat as many words as they can in a simulated noisy environment. Following the lab visit, participants will meet in a group with three other conversation partners in a real-world setting and asked to complete subjective questionnaires during the visit.
Participants will undergo a hearing aid fitting for both the Phonak device and the Competitor device A. In the lab, participants will be seated in the center of a 10-speaker array. Diffuse ecologically valid noise will be coming from all 10 speakers, while recorded sentences will be presented one at a time randomly from 4 speakers in front of the participant. Participants will be given two lists of 25 sentences for each hearing aid condition, and will repeat as many words as they can. Percentage correct will be calculated for each hearing aid condition. The second appointment will consist of a real-world visit to a local cafe, in which they will be seated at a table with three other conversation partners. During the cafe visit, participants will be asked to answer questions about their perceived speech clarity, ease of listening, and listening confidence with each of the two devices. Participants will be blinded as to which devices they are wearing for both the lab visit and the real world cafe visit.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Participants fit and tested with the Phonak device first, then the Competitor device A. | Experimental | Participants that are tested first with the Phonak device, and then with the Competitor device A. |
|
| Participants fit and tested with Competitor device A first, then with Phonak device. | Experimental | Participants that are tested first with the Competitor device A, then with the Phonak device. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Phonak Audeo Infinio Hearing Aid | Device | Phonak Audeo Infinio RIC |
|
| Measure | Description | Time Frame |
|---|---|---|
| AZBio Sentence Test | A validated speech perception test consisting of 25 different lists of sentences. Sentences are presented via a loudspeaker at a pre-determined level and the number of words correctly repeated are calculated into a percenteage. The higher the percentage, the better the participant's speech perception. | Day 1 of study |
| Measure | Description | Time Frame |
|---|---|---|
| Composite Questionnaire | A 5-point Likert scale questionnaire that asks participants to rate the speech clarity, ease of listening, and listening confidence for each hearing aid. The scale is from 1 = Strongly disagree, to 5 = Strongly agree. Participants will be given this questionnaire following the AZBio Sentence test in the lab, and following the group conversation in the cafe. | Days 1 and 2 of study |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Phonak Audiology Research Center | Aurora | Illinois | 60504-7940 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D034381 | Hearing Loss |
| ID | Term |
|---|---|
| D006311 | Hearing Disorders |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D012678 | Sensation Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Participants will be blinded as to which hearing aid they are wearing during all of the testing.
| Competitor Device A | Device | Competitor Device A |
|
| D009461 |
| Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |